Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avanafil Dose Escalation in Erectile Dysfunction (SPEED)
NCT01705197Phase 3Completed
- Sponsor
- JW Pharmaceutical Corporation
- Start
- Feb 2012
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of avanafil in erectile dysfunction (ED), sponsored by JW Pharmaceutical Corporation. Started Feb 2012; status: completed.
02
Drugs
avanafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT01705197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01705197.